ViaCord has recruited experienced thought leaders in the field of stem cell transplantation and cord blood preservation as our Medical Scientific Advisors. Their broad-ranging expertise and guidance has kept ViaCord at the forefront of these fields.
Mark Walters, M.D.
Dr. Walters is Director of the Blood and Marrow Transplantation Program at Children's Hospital & Research Center, Oakland and Associate Adjunct Professor of Pediatrics at the Univ. of Calif. San Francisco School of Medicine. His focus of interest is in hematopoietic cell transplantation for non-malignant conditions, and in particular, in studying umbilical cord blood transplantation for hemoglobin disorders.
Barbara E. Bierer, M.D.
Dr. Bierer is the Sr. VP for Research at Brigham and Women's Hospital and Professor of Medicine and Pediatrics at Harvard Medical School. Previously, she was the Chief of the Laboratory of Lymphocyte Biology at the National Heart, Lung and Blood Institute in Bethesda, MD. She also served as Director of Pediatric Stem Cell Transplantation at the Dana-Farber Cancer Institute and Children's Hospital, Boston.
Bertram H. Lubin, M.D.
Dr. Lubin has been a scientific advisor since August 2006. He is currently President of Children's Hospital Oakland Research Institute (CHORI) and an Adjunct Professor of Pediatrics at the University of California, San Francisco. Over the past 35 years he has been involved in a number of clinical and basic research projects including work in the area of sickle cell disease and thalassemia at Children's Hospital of Philadelphia and Children's Hospital Oakland. He started the first sibling donor cord blood program in the world and serves on a number of national committees related to cord blood banking. Dr. Lubin received his M.D. from the University of Pittsburgh Medical School, his Pediatric training at the Children's Hospital of Philadelphia, where he was Assistant Chief Resident, and completed a fellowship in hematology/oncology at Children's Hospital Medical Center, Boston. He was an Assistant Professor of Pediatrics at the University of Pennsylvania and Director of the Sickle Cell Program prior to moving to Children’s Hospital Oakland.
George Q. Daley, M.D., Ph. D.
Dr. Daley is Co-Chairman of our Medical and Scientific Advisory Board. He is an Associate Professor in Pediatric Hematology/Oncology at Children's Hospital and Dana- Farber Cancer Institute, and Harvard Medical School. Previously, he was a Whitehead Fellow and Assistant Professor of Medicine at Massachusetts General Hospital.
Graham Molineaux, Ph.D.
Dr. Molineux has been a scientific advisor since November 2005. He is currently Director of Hematology and Oncology Research at Amgen Inc. Before joining Amgen in 1994 he spent nearly 20 years at the Paterson Institute for Cancer Research at Christie Hospital in Manchester, England. He trained at University of Manchester specializing in stem cell biology. Dr. Molineux received his Ph.D. from the University of Manchester Institute of Science and Technology, an M.S. in Experimental Immunology and Oncology and a B.S. from Liverpool University.
Leonard I. Zon, M.D.
Dr. Zon is an attending physician in Hematology at Children's Hospital, Boston, and in Oncology at Dana-Farber Cancer Institute. He is an Associate in Medicine Hematology/Oncology at Children's Hospital and Professor of Pediatric Medicine at Harvard Medical School. He is also an Investigator for Howard Hughes Medical Institute.